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Background: Non communicable disease (NCD) multimorbidity is increasingly becoming common in high income
settings but little is known about its epidemiology and associated impacts on citizens and health systems in low
and middle-income countries (LMICs). We aim to examine the socio-demographic distribution of NCD multimorbidity
(≥2 diseases) and its implications for health care utilization and out-of-pocket expenditure (OOPE) in India.
Methods: We analyzed cross-sectional nationally representative data from the World Health Organisaion Study on
Global Ageing and Adult Health (WHO-SAGE), conducted in India during 2007. Multiple logistic regression was used
to determine socio-demographic predictors of self-reported multimorbidity. A two part model was used to assess the
relationship between number of NCDs and health care utilization including OOPE.
Results: 28.5% of the sample population had at least one NCD and 8.9% had NCD multimorbidity. The prevalence of
multimorbidity increased from 1.3% in 18–29 year olds to 30.6% in those aged 70 years and above. Mean outpatient
visits in the preceding 12 months increased from 2.2 to 6.2 and the percentage reporting an overnight hospital stay in
the past 3 years increased from 9% to 29% in those with no NCD and ≥2 NCDs respectively (p <0.001).
OOPE incurred during the last outpatient visit increased from INR 272.1 (95% CI = 249.0-295.2) in respondents with no
NCDs to INR 454.1 (95% CI = 407.8-500.4) in respondents with ≥2 NCDs. However, we did not find an increase in OOPE
during the last inpatient visit with number of NCDs (7865.9 INR for those with zero NCDs compared with 7301.3
for those with ≥2 NCDs). For both outpatient and inpatient OOPE, medicine constitutes the largest proportion of
spending (70.7% for outpatient, 53.6% for inpatient visit), followed by spending for health care provider (14.0% for
outpatient, 12.2% for inpatient visit).
Conclusion: NCD multimorbidity is common in the Indian adult population and is associated with substantially higher
healthcare utilization and OOPE. Strategies to address the growing burden of NCDs in LMICs should include efforts to
improve the management of patients with multimorbidity and reduce associated financial burden to individuals and
households.
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Improvements in living conditions, changing lifestyles and
progress in healthcare effectiveness have led to an increase
in the prevalence of non-communicable diseases (NCDs)
globally [1,2]. Much attention has been focused on the
increasing burden of single or selected NCD groupings,
especially diabetes and cardiovascular diseases [3]. Yet re-
cent epidemiological studies suggest that the prevalence of
NCD multimorbidity is high and increasingly the norm
for patients in high income settings [4]. For example, a
general practice database study conducted in Scotland
found that over half of the patients (54.9%) with at least
one NCD had multimorbidity [5].
International bodies and individual health systems are
increasingly recognizing the importance of NCDs [6,7].
However, most policy responses to date emphasize im-
proving the identification and management of individual
diseases [8,9]. For example, a series of national service
frameworks introduced in the UK’s National Health Ser-
vice since 2000 are focused on single conditions, such as
coronary heart disease. Other quality improvement strat-
egies, including clinical guidelines and pay for performance
programs, are similarly focused in single disease areas [10].
These approaches are increasingly at odds with growing in-
formation that patients with multimorbidity have higher
health service utilization, health care expenditure and
poorer health outcomes [11]. For example, a study of US
Medicare population found that the risk of an avoidable in-
patient admission and per capita medical expenditures in-
crease dramatically with the number of chronic conditions
[12-14]. The situation is not different in low and middle
income countries (LMICs). In India, most of the current
health programs have singular disease specific vertical
approach [15,16]. There is little information about the
epidemiology of NCD multimorbidity and associated
impacts on citizens and health systems in LMICs. This is
an important knowledge gap given the growing burden of
NCDs, the limited capacity of health systems to manage
this burden and the low levels of financial protection in
LMICs, resulting in a high level of out-of-pocket expendi-
tures. Our study assessed the prevalence and predictors of
NCD multimorbidity and associated impacts on health




We used cross-sectional data from the WHO Study on
Global Ageing and Adult Health (SAGE) wave 1 survey
of India, 2007, carried out by the International Institute
for Population Sciences, Mumbai with the technical as-
sistance from World Health Organization. The WHO
SAGE survey took representative samples of six states in
India (Assam, Karnataka, Maharashtra, Rajasthan, UttarPradesh and West Bengal) which can be modelled to a na-
tionally representative sample. The survey consisted of a
large sample of people aged 50 years and older and a
smaller comparative sample aged 18–49 years, with 12,198
respondents (4,717 men, 7,481 women) in total. The SAGE
dataset is described in full elsewhere [17] and the ques-
tionnaires can be found at http://www.who.int/healthinfo/
sage/cohorts/en/index2.html (accessed 18 August 2013).
The SAGE survey covers a broad range of topics, in-
cluding health and its determinants, disability, subjective
well-being, emotional and financial well-being, health
care utilization, and health systems responsiveness. SAGE
has included methodologies to improve cross-population
comparability of self-reported health and well-being data
through the inclusion of biomarkers, performance tests,
anchoring vignettes, and additional validation studies
[17]. The survey was conducted using an interviewer-
administered questionnaire in the native language of the
respondent using local, commonly understood terms. A
total of five languages with back translation to English
were used in the Indian survey to ensure accuracy and
comparability.
SAGE has also worked to harmonize methods and re-
sults with a number of studies, including the U.S. Health
and Retirement Study, Chinese Health and Retirement
Longitudinal Study, and Longitudinal Aging Study in
India [17]. For further details refer to the SAGE Wave 1
survey manual and questionnaires (available at http://
www.who.int/healthinfo/sage/cohorts/en/index2.html).
For the purpose of the study, we included respondents
aged ≥18 years, and excluded those with missing values
for outcome and independent variables (9.2% of the sam-
ple). As some respondents did not provide a response for
out-of-pocket expenditure for their last visit, our estima-
tions were based on samples, who answered positively on
this question, but included those who replied that their
treatment cost was free. In addition, to lessen the influ-
ence of outliers, we remove observations with the highest
0.5% of outpatient/inpatient out-of-pocket spending.
Variables
Outcome measures
Our main outcome measure was the number of NCDs re-
ported by the respondents. Respondents were asked if
they had been diagnosed with any of the following NCDs:
angina, arthritis, asthma, cataract, diabetes (excluding dia-
betes associated with a pregnancy), stroke, chronic lung
disease, hypertension and depression. The question asked
was, “Have you ever been told by a health professional
that you have . . . ?”, or “Have you ever been diagnosed
with . . . ?” for each health condition. We defined multi-
morbidity as the presence of two or more above listed
conditions. No standard approach for the measurement of
multimorbidity exists, and selection and definition of
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jective and dependent on the data available [5].
Respondents were asked about their utilization of out-
patient (number of visits in the past 12 months) and
hospital care (whether or not overnight stay in the past
3 years, and number of stays in past 12 months). Details
about OOPE for health care provider fees, medicines,
diagnostic tests and transport costs during their last out-
patient visit and last hospital stay were elicited from re-
spondents, in Indian Rupees (INR).Predictor variables/covariates
Socio-economic and demographic factors included in
our analysis were age groups (18–29, 30–39, 40–49, 50–
59, 60–69, 70+ years); gender; caste/tribe status (general,
scheduled caste and tribe, other backward classes); mari-
tal status (married, not married), education (primary
school or less, secondary school completed, tertiary or
higher education); location (rural, urban); state (Assam,
Karnataka, Maharashtra, Rajasthan, Uttar Pradesh, West
Bengal), quintiles of household wealth/assets, (Q1 lowest
to Q5 highest) and health insurance status (with/without
health insurance). The household wealth variable pro-
vided in the dataset was derived using WHO standard
approach to estimating permanent income from survey
data on household ownership of durable goods, neigh-
borhood and dwelling characteristics, and access to
water, sanitation, electricity etc. [18].Statistical analysis
We used multiple logistic regression to determine socio-
economic and demographic predictors of having any
chronic condition or multimorbidity. We used a two-part
model to assess the association between NCDs (coded as
a continuous variable begins from zero) and health care
utilization. In this model, we estimated whether the re-
spondent had any outpatient or inpatient visit (binary re-
sponse) using a logistic model, and estimated the number
of outpatient visits or hospitalization days (count re-
sponse) using a negative binomial model. We presented
adjusted odds ratio (AOR) from logistic model, and coeffi-
cient from negative binomial model.
We estimated the average amount of OOPE by number
of NCDs. We also presented the proportion of OOPE by
categories of spending.
We tested for multicollinearity for covariates adjusted
for in our analysis. The multicollinearity diagnostics
(VIF) were all less than 5, indicating that the assumption
of reasonable independence among predictor variables
was met. Sampling weights were used to account for the
complex, multi-stage design of the SAGE survey. We per-
formed the statistical analyses using Stata 13.1 (StataCorp,
College Station, Texas).Ethics approval
The WHO SAGE study received human subjects testing
and ethics council approval from research review boards
local to each participating site, and from the WHO Ethical
Review Committee. The study was approved by Institu-
tional Ethical Committee, Indian Institute of Public Health-
Bhubaneswar. Informed consent was obtained from each
respondent prior to interview and examination.
Results
We analyzed data from 10,973 respondents. Table 1 pre-
sents respondents’ socioeconomic and demographic char-
acteristics of the respondents. The median age of the
respondents was 40 years (IQR = 30-49). There were about
equivalent proportion of female and male respondent,
82.1% were married, 61.5% of the respondents have educa-
tional attainment of primary school completed or less, and
25.7% were residing in urban area.
Socio-demographic predictors of NCD multimorbidity
The socio-economic and demographic characteristics of
the study population by the number of NCDs are also
presented in Table 1. The mean number of NCDs in the
sample was 0.42 with 28.5% (95% CI = 26.8%-30.3%)
hadany NCD, and 8.9% (95% CI = 8.0% -9.8%) had multi-
morbidity. The mean number of NCDs increased with
age, in urban people and with increasing household in-
come but did not significantly differ by gender or educa-
tion. The prevalence of NCD multimorbidity increased
substantially with age, from 1.3% (95% CI = 0.7-1.9%) in
18–29 year olds to 30.6% (95% CI = 25.7-35.5%) in those
aged 70 years and above, AOR = 39.2 (95% CI = 20.7-
74.0, for those aged 70 years and above compared to
those aged 18–29 years). The prevalence of NCD multi-
morbidity increased substantially with increasing house-
hold wealth, from 6.8% (95% CI = 5.0%-8.5%) in the
lowest wealth quintile to 10.7% (95% CI = 9.0%-12.4%) in
the highest wealth quintile.
Health care utilization by number of NCDs
NCD multimorbidity is associated with greater health-
care utilization in primary and secondary care (Figure 1,
Table 2). The percentage of participants reporting having
any outpatient visits in the last year increased from 71%
in those with no NCDs to 83% in those with 3+ NCDs
(AOR = 1.55, p-value <0.0001). The mean number of visits
to an outpatient department in the preceding 12 months
increased from 2.24 in respondents with no NCDs to 6.16
in those with 3+ NCDs (regression coefficient = 0.28,
p-value <0.0001). The percentage of participants report-
ing an overnight hospital stay in the past 3 years increased
from 9% in those with no NCDs to 29% in those with 3+
NCDs (AOR = 1.59, p-value <0.0001). The mean number
of stays in hospital in the past year increased from 0.06 in














18-29 1565 (24.0) 89.8 (87.6, 92.0) 9.0 (6.8, 11.1) 1.3 (0.6, 1.9) 1.00 (Ref) 1.00 (Ref)
30-39 1619 (25.2) 78.3 (75.4, 81.2) 16.9 (14.2, 19.6) 4.8 (3.4, 6.2) 2.67 (1.97, 3.62) 4.11 (2.18, 7.74)
40-49 1378 (26.0) 68.1 (64.3, 71.8) 23.2 (20.1, 26.4) 8.7 (6.5, 10.9) 4.53 (3.40, 6.03) 7.87 (4.25, 14.59)
50-59 2868 (12.1) 57.2 (54.4, 60.0) 26.3 (23.7, 28.9) 16.5 (14.0, 18.9) 7.05 (5.42, 9.16) 16.15 (8.83, 29.54)
60-69 2185 (7.7) 47.1 (43.8, 50.5) 31.6 (28.2, 35.1) 21.3 (18.4, 24.1) 10.91 (8.24, 14.45) 23.56 (13.08, 42.44)
70+ 1358 (5.1) 38.6 (33.9, 43.3) 30.8 (27.0, 34.5) 30.6 (25.7, 35.5) 15.27 (11.06, 21.09) 39.15 (20.72, 73.98)
Gender
Male 4242 (50.9) 71.7 (68.9, 74.5) 19.5 (17.2, 21.7) 8.8 (7.4, 10.2) 1.00 (Ref) 1.00 (Ref)
Female 6731 (49.1) 71.2 (69.4, 73.0) 19.7 (18.0, 21.5) 9.1 (8.1, 10.1) 1.15 (0.96, 1.39) 1.19 (0.97, 1.47)
Location
Rural 8180 (74.3) 72.3 (70.5, 74.2) 19.3 (17.8, 20.8) 8.3 (7.3, 9.3) 1.00 (Ref) 1.00 (Ref)
Urban 2793 (25.7) 68.9 (65.0, 72.8) 20.4 (17.5, 23.3) 10.7 (8.7, 12.7) 0.97 (0.78, 1.19) 1.03 (0.79, 1.34)
State
Assam 1106 (5.6) 73.7 (69.2, 78.1) 18.5 (14.8, 22.3) 7.8 (5.2, 10.3) 1.00 (Ref) 1.00 (Ref)
Karnataka 1538 (12.0) 57.8 (52.2, 63.4) 24.8 (20.8, 28.7) 17.4 (13.8, 21.1) 1.70 (1.18, 2.45) 2.38 (1.36, 4.14)
Maharashtra 1958 (20.5) 71.3 (67.2, 75.3) 19.5 (16.5, 22.5) 9.2 (7.5, 10.9) 1.01 (0.73, 1.39) 0.99 (0.63, 1.56)
Rajasthan 2191 (12.2) 81.7 (78.2, 75.2) 13.6 (11.3, 15.9) 4.7 (3.1, 6.3) 0.57 (0.41, 0.81) 0.52 (0.31, 0.87)
Uttar Pradesh 2167 (32.9) 72.5 (69.3, 75.7) 20.1 (17.2, 23.0) 7.4 (5.6, 9.1) 1.03 (0.74, 1.44) 0.84 (0.52, 1.35)
West Bengal 2013 (16.8) 71.2 (66.3, 76.2) 19.8 (16.5, 23.1) 9.0 (6.2, 11.8) 1.09 (0.77, 1.55) 1.06 (0.61, 1.84)
Caste/tribe status
General 6401 (60.9) 75.1 (69.7, 80.6) 16.4 (13.8, 19.0) 8.7 (5.5, 11.9) 1.00 (Ref) 1.00 (Ref)
Scheduled tribes 752 (6.4) 77.5 (74.3, 80.7) 16.4 (13.8, 19.0) 6.1 (4.6, 7.7) 0.88 (0.63, 1.23) 1.02 (0.67, 1.56)
Scheduled castes 1946 (19.2) 59.8 (54.7, 64.9) 24.9 (21.1, 28.7) 15.2 (12.3, 18.2) 0.76 (0.60, 0.98) 0.75 (0.52, 1.06)
Other backward class 1874 (13.5) 71.7 (69.6, 73.9) 19.8 (18.0, 21.6) 8.5 (7.3, 9.6) 1.16 (0.80, 1.68) 0.94 (0.54, 1.63)
Marital status
Married 8522 (82.1) 71.5 (69.6, 73.4) 19.7 (18.2, 21.2) 8.8 (7.8, 9.9) 1.00 (Ref) 1.00 (Ref)
Not married 2451 (17.9) 71.3 (67.8, 74.8) 19.2 (16.4, 22.1) 9.5 (7.9, 11.1) 1.08 (0.87, 1.34) 0.95 (0.75, 1.21)
Education
Primary school or less 7797 (61.5) 69.9 (68.1, 71.8) 20.4 (18.9, 22.0) 9.6 (8.6, 10.6) 1.00 (Ref) 1.00 (Ref)
Secondary School 1369 (15.7) 74.5 (70.7, 78.2) 17.2 (14.1, 20.3) 8.4 (6.0, 10.7) 1.12 (0.89, 1.41) 1.43 (1.03, 1.98)
Tertiary or higher 1807 (22.8) 73.5 (69.7, 77.2) 19.0 (15.7, 22.4) 7.5 (5.6, 9.4) 1.12 (0.87, 1.43) 1.15 (0.86, 1.55)
Household wealth
Q1 (low) 1959 (20.6) 74.8 (71.6, 78.0) 18.4 (15.7, 21.2) 6.8 (5.0, 8.5) 1.00 (Ref) 1.00 (Ref)
Q2 2115 (21.3) 75.1 (72.2, 77.9) 17.2 (14.4, 19.9) 7.8 (5.7, 9.8) 0.94 (0.74, 1.19) 1.09 (0.72, 1.67)
Q3 2095 (19.8) 70.4 (66.5, 74.3) 20.5 (17.3, 23.8) 9.1 (7.1, 11.0) 1.22 (0.95, 1.56) 1.24 (0.88, 1.74)
Q4 2315 (18.0) 68.3 (64.9, 71.7) 21.0 (17.7, 24.3) 10.7 (8.6, 12.7) 1.20 (0.93, 1.54) 1.29 (0.90, 1.84)
Q5 (high) 2489 (20.2) 68.1 (64.9, 71.3) 21.2 (18.4, 24.1) 10.7 (9.0, 12.4) 1.29 (0.99, 1.68) 1.35 (0.94, 1.95)
Insurance status
With insurance 443 (3.3) 61.9 (53.8, 70.0) 25.6 (19.0, 32.1) 12.5 (6.7, 18.3) 1.00 (Ref) 1.00 (Ref)
Without insurance 10530 (96.7) 71.8 (70.0, 73.5) 19.4 (18.0, 20.8) 8.8 (7.9, 9.7) 0.96 (0.65, 1.42) 1.24 (0.68, 2.25)
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Figure 1 Association between number of NCDs and health care utilisation.
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gression coefficient = 0.49, p-value < 0.0001). Overall, our
results suggested a positive association between number
of NCDs and health care utilization for both outpatient
and inpatient services.
Out-of-pocket expenditure (OOPE) by number of NCDs
The average out-of-pocket spending for outpatient and
inpatient service by NCDs are presented in Table 3. We
also presented the proportion of out-of-pocket spending
by type of service. The OOPE incurred during the last
outpatient visit increased from INR 272.1 (95% CI =
249.0-295.2) in respondents with no NCDs to INR 454.1
(95% CI = 407.81-500.35) in respondents with 2+ NCDs.
However, we did not find inpatient OOPE during the
last visits increased with number of NCDs (7865.9 INR
for those with zero NCDs compared with 7301.3 for
those with 2+ NCDs). For both outpatient and inpatient
OOPE, medicine constitutes the largest proportion of
spending (70.7% for outpatient, 53.6% for inpatient visit),
followed by spending for health care provider (14.0% for
outpatient, 12.2% for inpatient visit). There is also a
non-trivial proportion of OOPE on transport (8.3% for
outpatient and 11.8% for inpatient visit), and medical
test (4.4% for outpatient and 10.5% for inpatient service).Table 2 Association between NCDs and health care
utilization




Any outpatient visit 0.71 0.84 0.88 0.83 1.55 <0.0001
Number of
outpatient visit
2.24 3.22 4.46 6.16 0.28 <0.0001
Inpatient visits
Any inpatient visit 0.09 0.15 0.23 0.29 1.59 <0.0001
Number of
hospitalisation days
0.06 0.14 0.19 0.33 0.49 <0.0001This pattern of spending did not alter significantly for
patients with different number of NCDs.
Discussion
NCD multimorbidity is increasingly common globally with
growing implications for the management of individual pa-
tients, assessment of disease burden in populations and
health system efficiency and effectiveness [5,19]. However,
very little research has been undertaken in LMICs, where
80% of the burden of NCDs falls [20]. Our study reveals
that more than one in four adults in India has at least one
NCD, with 8.9% having two or more NCDs. We found no
significant difference in the prevalence of multimorbidity
across gender or educational attainment. Multimorbidity
appears to be more common in affluent households and
there is a dramatic rise in prevalence with age, increasing
from 1.3% in the youngest group (18–29 years) to 30.6% in
the oldest (≥70 years).
The prevalence of multimorbidity in our study appears
to be lower than that reported in high income countries.
A study conducted in Spain in 2007 has shown that 42%
of the registered population aged 14 years and above had
at least one chronic condition, with almost one quarter
having multimorbidity [21]. Another study undertaken in
a family practice settings in Canada has reported nine out
of ten patients to have more than one chronic condition
[22]. It should be noted that most of these studies have
been conducted in primary care practice populations,
using clinical and administrative databases [22-25]. The
prevalence of multimorbidity when estimated in general
population surveys has been found to be lower than when
examined using clinical databases [26], partly due to
the more limited numbers of conditions (only eight dis-
eases in our study) included in these analyses. Thus, esti-
mation studies preferably in primary care settings using
broad nosological spectrum of chronic conditions would
be insightful.
Our study confirms previous findings from high income
countries that multimorbidity increases with age [21-23].
Table 3 NCDs and out-of-pocket expenditure by categories
Number of NCDs
Outpatient
Total OOPE (95% CI) Health care provider (%) Medicines (%) Medical test (%) Transport (%) Others (%)
All 308.9 (259.59, 328.27) 14.03% 70.71% 4.42% 8.30% 2.54%
0 272.07 (248.95, 295.18) 13.19% 73.55% 3.22% 7.57% 2.47%
1 356.79 (318.41, 395.17) 15.76% 66.23% 5.83% 9.38% 2.81%
2+ 454.08 (407.81, 500.35) 16.00% 61.05% 9.55% 10.90% 2.50%
Number of NCDs
Inpatient
Total OOPE (95% CI) Health care provider (%) Medicines (%) Medical test (%) Transport (%) Others (%)
All 7483.6 (6486.1, 8481.1) 12.16% 53.62% 10.49% 11.82% 11.92%
0 7864.9 (6215.5, 9514.4) 12.06% 55.92% 9.24% 11.68% 11.10%
1 6847.68 (5121.7, 8573.7) 10.56% 52.36% 12.01% 12.77% 12.30%
2+ 7301.33 (5234.6, 9368.1) 14.47% 49.21% 11.80% 10.97% 13.56%
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tions between gender and multimorbidity, with some
studies indicating a higher prevalence in women while
others found similar results in men [24,27,28]. Recent
studies emphasize the importance of examining multimor-
bidity across life course and not just the elderly population
[29]. However NCD prevalence estimates in women
should be interpreted cautiously in South Asian context,
where they may have lower health care seeking behavior
[30]. The possible interplay of multimorbidity with social
and economic deprivation has already been identified.
Studies conducted in high income countries have gener-
ally found that persons with low socio-economic status
(SES) are more likely to have multimorbidity when com-
pared to their affluent counterparts [31]. However, we did
not find similar evidence in our study. A study from
Bangladesh has also reported the prevalence to be more
in high income group [32]. This might be due to higher
health literacy levels and more frequent utilization of health
care facilities in higher income groups [33].
The presence of multimorbidity was associated with
substantially higher levels of health care utilization, in
both outpatient and hospital settings, and markedly with
higher levels of OOPE in our study. These findings are
consistent with those from previous studies conducted
in high income settings which have identified a positive
correlation between multimorbidity with health care
utilization and cost [14,34,35]. For example, a recent
Scottish study found that persons with multimorbidity
were six times more likely to have an unplanned hospital
admission [11]. Our study builds on previous research in
India which has documented the impoverishing impact
of health care costs among persons with NCDs, wherein
nearly half of OOPE was incurred in the purchase of
medicine, diagnostic investigations and medical appli-
ances [36]. We too observed that more than 50% of total
expenditure is spent towards getting medicines. However,out of pocket expenditure was not specific for NCDs,
and might have included treatment for conditions not
related to NCDs The impact of multimorbidity alone
on catastrophic and impoverishing household health
care spending in LMICs merits further investigation
[37]. It would be interesting first to investigate, what
proportion of the identified demand of chronic health-
care is being currently delivered in primary care practice
and the consequential impact on OOPE if there is transfer
of healthcare services from specialist setting to primary
care settings.
The key strength of this study is the use of a na-
tionally representative sample; which permits robust
cross-sectional level estimates of key variables. We identify
certain limitations in our study. SAGE is a cross sectional
survey which limit the causal inference between multi-
morbidity and health care utilization and expenditure.
Identification of NCDs was based on self report of a doc-
tor diagnosis which may be biased due to a potential
under or over reporting and/or poor quality diagnosis.
This may result in greater under-reporting of NCDs in
persons from lower socio-economic status in particular
[38,39]. However, the amount of error may not have been
substantial since studies have documented that self re-
ported prevalence produce estimates near to true preva-
lence and simple disease counts may have equal predictive
value of morbidity burden when compared with other,
more complex measurement approaches to multimorbid-
ity [40,41]. With the available data, it was not possible to
measure the severity of the disease or its health impacts
on survey participants. Utilization and OOPE data were
based on self-report, and therefore subject to recall bias,
and only relate to the most recent episode of care. SAGE
did not include detailed questions about the presence of
communicable disease and although, reasons for health
care utilization were solicited from respondents, responses
were generally non-specific and incomplete. Given this,
Pati et al. BMC Health Services Research 2014, 14:451 Page 7 of 9
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sions in these outcome measures which could have in-
cluded some health care utilization that is unrelated to
NCDs.
The high prevalence of NCD multimorbidity identi-
fied here underlines the importance of current efforts
to strengthen health systems in many LMICs, including
India. It is essential that these efforts focus on strengthen-
ing primary care, given its key role in providing continu-
ous, well coordinated and comprehensive care to patients
with complex health needs including those with multiple
NCDs. This requires a shift away from current approaches,
which frequently emphasize vertical, disease specific
programs with primary care having a more limited role
around the management of acute illness. A collaborative,
patient-centerd approach accommodating multiple care
processes in primary care is required. Developing clinical
practice guidelines on managing multimorbidity for pri-
mary care practitioners is an important component of this
new approach. Current proposals to achieve universal
health coverage (UHC) in India highlight the import-
ance of primary care strengthening but need to be
cognizant of the rising burden of multimorbidity and work
to strengthen health system and individual practi-
tioner responsiveness to this challenge. The financial bur-
den of having multiple NCDs highlights the importance of
strengthening financial protection as part of universal
coverage proposals. Efforts to reduce the cost of medica-
tions, which are the major source of OOPE, are already
underway in India [42].
Further research is required to better understand the
epidemiology of multimorbidity and associated impacts
on health care utilization and costs in India and other
LMIC settings. Primary care records-based prevalence
studies may provide more definite estimates of the true
extent of the problem. It has been hypothesized that
clustering of diseases in multimorbidity could be under-
pinned with common etiology and thus looking at com-
monly occurring patterns through cluster analysis could
further elucidate the dynamics of co-morbidities [43]. As
cross sectional studies only reflect the diseases present
at the time of data collection, and their impact on other
domains is specific to this time, it would be more useful
to undertake longitudinal studies to understand the pro-
gression and impact of multimorbidity over time. Fur-
thermore, the consequences of multimorbidity on health
related quality of life, poly-pharmacy, therapeutic deci-
sion making and care preferences of patients need to be
investigated. The knowledge gained from such research
could help in aligning current strategies along with
prioritization of health services to prepare for the chal-
lenge of multimorbidity. A stronger primary care to deal
with multimorbidity in a cost effective way poses a chal-
lenging task ahead for the health systems in India.Conclusion
Our study provides evidence on the emerging burden of
NCD multimorbidity in the Indian context, highlighting
the need for better recognition by physicians, health plan-
ners and policy makers. Specifically our findings indicate a
need for the growing burden of multimorbidity to be con-
sidered within the context of health system planning,
encompassing workforce training and quality improvement
strategies, including the development of clinical guidelines
and quality indicators. Our findings reinforce the import-
ance of strengthening primary care systems in LMICs,
which is the most appropriate setting for these patients to
be managed, and emphasize the need to improve financial
protection in these settings. Further research is required to
better understand the epidemiology of multimorbidity and
associated impacts on health care utilization and costs in
India and other LMIC settings.
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